The Vitamin D Epidemic Nobody Is Talking About in Switzerland

Switzerland is one of the most health-conscious countries in Europe. It is also, due to its geography and climate, a country with pervasive vitamin D deficiency. Studies conducted by Swiss university hospitals show that 60–75% of adults have insufficient 25-OH vitamin D levels by February, with significant proportions falling into frank deficiency (<30 nmol/L).

Vitamin D is not simply "the sunshine vitamin" in the colloquial sense. It is a hormone — calcitriol — that regulates over 200 genes, modulates immune function, governs calcium homeostasis, and plays a direct role in insulin sensitivity, testosterone production, mood regulation, and the prevention of autoimmune disease.

What deficiency actually looks like

The symptoms of vitamin D insufficiency are almost universally attributed to other causes:

• Persistent fatigue (blamed on overwork or poor sleep)
• Low mood and seasonal affective disorder
• Frequent infections and slow recovery
• Bone pain and muscle weakness
• Poor concentration and brain fog

None of these are specific. All of them are routinely investigated for other causes — often for years — before vitamin D is checked.

The immune system connection

Perhaps the most consequential aspect of vitamin D deficiency is its effect on immune regulation. Vitamin D receptors (VDRs) are present on virtually every immune cell. Deficiency impairs the innate immune response, reduces the production of antimicrobial peptides, and — critically — shifts the immune system toward a pro-inflammatory state. This contributes to elevated hsCRP and IL-6, the same inflammatory markers associated with accelerated cardiovascular disease and neurodegeneration.

Why GPs don't routinely test it

Switzerland's KVG does not reimburse 25-OH vitamin D testing for asymptomatic individuals. The test costs CHF 35–55 privately. This is a rational cost-allocation decision at a population level and a clinically questionable one at an individual level — particularly for anyone over 45, with dark skin, limited sun exposure, or a history of autoimmune conditions.

Optimal vs. sufficient

The clinical threshold for "deficiency" is typically set at <50 nmol/L. However, research in immunology and oncology increasingly identifies the optimal range as 100–150 nmol/L. The gap between "not deficient" and "optimal" is substantial — and it matters, particularly for cancer prevention, immune resilience, and bone density preservation over 50.